Its technology is a way to grow and control cells without the need for any of those expensive recombinant proteins for cell production.
In the past year, there’s been a lot of hype around biomanufacturing — from growing cell-based meat to microbe-powered medicine manufacturing. But none of synthetic biology’s darlings ca
Vegetable oils like canola and palm oil have become a major part of our diet, whether we like it or not, and while they’re useful substances, they’re not exactly good for you and are a maj
Breakout Ventures, a San Francisco-based seed- and Series A-stage venture firm that funds what it calls creative biosciences startups, has closed the second fund in its five-year history with $112.5 m
Fifty Years, a six-year-old, San Francisco-based outfit with a portfolio that’s already rife with mostly deep tech companies — many with a good story to tell about how they can have an imp
The company will begin production of its first product offering, a variety of pork sausages, next year.
Late last year, Solugen, a startup using synthetic biology to take hydrocarbons out of the chemicals industry, decided against pursuing a new round of funding that would have valued the company at ove
Senti Biosciences, a company developing cancer therapies using a new programmable biology platform, said it has raised $105 million in a new round of financing led by the venture arm of life sciences
Daniel Arlow has spent the last eighteen years studying genomics and synthetic biology. The arc of his career has taken the first-time founder of the new startup Ansa Biotechnologies from MIT to the f
There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promi
From a partnership with the Russian company 3D Bioprinting Solutions to make chicken meat replacement using plant material and lab-cultured chicken cells to an expansion of its Beyond Fried Chicken pi
Octant, a company backed by Andreessen Horowitz just now unveiling itself publicly to the world, is using the tools of synthetic biology to buck the latest trends in drug discovery. As the pharmaceuti
Novameat, a Spanish startup looking to accelerate the development of alternative proteins across the meat aisle, has gotten a boost in the form of new investment capital from the leading foodtech inve
DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that
We put together a list of venture funds operated by some of the larger food and beverage producers, covering literally everything from soup to nuts (plus lunch meat and soda, too!).
The pace at which the scientific breakthroughs working to bend the machinery of life to the whims of manufacturing have transformed into real businesses has intensified competition in the biomanufactu
The venture investment arm of massive meat manufacturer Tyson Foods is continuing its push into potential alternative methods of poultry production with a new investment in the Israeli startup Future
A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a
A Brooklyn-based startup called Modern Meadow has raised $40 million to become a top source of leather for the world’s makers of fashion and accessories, luggage, sporting goods, upholstery and furn
The debates in Congress will be ugly, uninformed, and emotional. Lawmakers won’t know which side to pick and will flip flop between what lobbyists ask and the public’s fear du jour.